Share on StockTwits

Applied Genetic Technologies Corp (NASDAQ:AGTC) was the recipient of a significant decline in short interest in August. As of August 15th, there was short interest totalling 443,766 shares, a decline of 37.7% from the July 31st total of 711,984 shares, Stock Ratings Network.com reports. Based on an average daily trading volume, of 52,207 shares, the days-to-cover ratio is presently 8.5 days. Approximately 6.8% of the shares of the stock are sold short.

A number of analysts have recently weighed in on AGTC shares. Analysts at Cantor Fitzgerald raised their price target on shares of Applied Genetic Technologies Corp from $21.00 to $24.00 in a research note on Thursday, August 21st. They now have a “buy” rating on the stock. Analysts at BMO Capital Markets raised their price target on shares of Applied Genetic Technologies Corp from $21.00 to $34.00 in a research note on Monday, June 9th. They now have an “outperform” rating on the stock.

Shares of Applied Genetic Technologies Corp (NASDAQ:AGTC) opened at 15.88 on Thursday. Applied Genetic Technologies Corp has a 52 week low of $11.10 and a 52 week high of $34.37. The stock’s 50-day moving average is $17.72 and its 200-day moving average is $17.89. The company’s market cap is $255.4 million.

Applied Genetic Technologies Corp is a United States-based clinical stage biotechnology company. The Company develops gene therapy products for the treatment of inherited and acquired diseases.

Receive News & Ratings for Applied Genetic Technologies Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Applied Genetic Technologies Corp and related companies with Analyst Ratings Network's FREE daily email newsletter.